I wonder if, considering the medical needs of patients and the situation that has arisen, if management has talked to the FDA about moving up the Nov 13th date for review of the new contractor's facility to a date as soon as possible so that, if approved, we can get the product back onto the market as soon as possible? It would be the right thing to do in all cases!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.